Video centre

Learn more about the design of SHINGRIX

00:00
00:00

Discover the components and the mechanism of action of SHINGRIX.

View reconstitution instructions for SHINGRIX

00:00
00:00

You and your office staff can learn how to administer SHINGRIX step by step.

Who’s at risk of developing shingles?

00:00
00:00

Are your patients over 50 aware of their risk of developing shingles?

The burden of shingles

00:00
00:00

Shingles can result in a painful and blistering rash that can last several weeks.
SHINGRIX is not indicated for the treatment of HZ or PHN.

SHINGRIX: A 2-dose vaccine developed to prevent shingles

00:00
00:00

Discover the importance of the second dose of SHINGRIX.

NACI recommendation for herpes zoster vaccination

00:00
00:00

Review the recommendation from the National Advisory Committee on Immunization (NACI) on SHINGRIX.

Trademarks are owned by or licensed to the GSK group of companies.

©2024 GSK Group of companies or its licensor.

10572 | 05/24